Strategic Science & Technologies, LLC   Report issue

For profit Phase 2 Phase 3
Founded: Cambridge MA United States (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2013
NCT01874626
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Strategic Science & Technologies, LLC